PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and ...

Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...

The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...